Page 1 of Clinical Trials for Other No treatment, 19848 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options
Last Updated: June 2, 2011
Condition(s): HIV Infections
2
Approved for marketing
TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.
Last Updated: February 7, 2012
Condition(s): HIV Infections
3
Recruiting
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
Last Updated: February 3, 2012
Condition(s): Hunter Syndrome
4
Active, not recruiting
Neurocognitive Assessment in Youth Initiating HAART
Last Updated: December 2, 2011
Condition(s): HIV Infections
5
Active, not recruiting
An Investigator-blind Multi-center Prospective Study for the Efficacy and Safety of Silicon Gel (Dermatix)
Last Updated: December 9, 2010
Condition(s): Hypertrophic Cicatrix
6
Completed
A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available
Last Updated: October 12, 2011
Condition(s): Advanced Solid Tumors
7
Recruiting
Neuroprotection and Repair in Optic Neuritis
Last Updated: March 4, 2010
Condition(s): Multiple Sclerosis; Optic Neuritis; Minocycline
8
Enrolling by invitation
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
Last Updated: January 24, 2012
Condition(s): Diabetes; Diabetes Mellitus, Type 2; Medullary Thyroid Carcinoma
9
Not yet recruiting
Treatment Of Radiation Retinopathy Trial
Last Updated: June 30, 2009
Condition(s): Uveal Melanoma
10
Enrolling by invitation
Computerized Personal Interventions for Alzheimer's Patients
Last Updated: April 3, 2011
Condition(s): Alzheimer's Disease
11
Approved for marketing
The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.
Last Updated: May 4, 2012
Condition(s): HIV-1
12
Withdrawn
Paricalcitol for the Treatment of Immunoglobulin A Nephropathy
Last Updated: January 29, 2009
Condition(s): IGA Nephropathy
13
Completed
Study to Evaluate Restylane Vital Light Using an Injector Device
Last Updated: August 8, 2011
Condition(s): Aesthetics
14
Completed
Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy
Last Updated: November 26, 2008
Condition(s): Lymphoma, Non-Hodgkin
15
Completed
A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome
Last Updated: March 7, 2012
Condition(s): Clinically Isolated Syndrome
16
Completed
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Children With Type 1 Diabetes
Last Updated: January 25, 2012
Condition(s): Diabetes; Diabetes Mellitus, Type 1
17
Recruiting
Corticosteroid Therapy for Glucocorticoid Insufficiency Related to Traumatic Brain Injury
Last Updated: December 26, 2011
Condition(s): Traumatic Brain Injury; Trauma; Adrenal Insufficiency; Pneumonia
18
Recruiting
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Last Updated: March 14, 2012
Condition(s): Hairy Cell Leukemia (HCL); Chronic Lymphocytic Leukemia (CLL); Non-Hodgkins Lymphoma (NHL); Cutaneous T Cell Lymphoma (CTCL); Adult T Cell Lymphoma (ATL)
19
Terminated
Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.
Last Updated: December 16, 2008
Condition(s): Pancreatic Cancer
20
Recruiting
Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse
Last Updated: September 26, 2011
Condition(s): Multiple Myeloma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Other+No+treatment

Page 1 of Clinical Trials for Other No treatment, 19848 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About